Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pyrazolanthrone

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with pyrazolanthrone in 2 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(pyrazolanthrone)		Trials
(pyrazolanthrone)		Recent Studies (post-2010) (pyrazolanthrone)
9,1561875521,4842765

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)pyrazolanthrone (IC50)
Chain A, Mitogen-activated protein kinase 10Homo sapiens (human)0.15
Chain A, Mitogen-activated protein kinase 10Homo sapiens (human)0.15
Chain A, Mitogen-activated protein kinase 10Homo sapiens (human)0.15
TPA: protein transporter TIM10Saccharomyces cerevisiae S288C20.2
TPA: protein transporter TIM23Saccharomyces cerevisiae S288C6.31
Serine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)0.72
Interferon-induced, double-stranded RNA-activated protein kinaseHomo sapiens (human)8
Dual specificity protein kinase TTKHomo sapiens (human)0.8987
Mitogen-activated protein kinase 8Homo sapiens (human)0.921
Mitogen-activated protein kinase 9Homo sapiens (human)1.0111
Tyrosine-protein kinase JAK3Homo sapiens (human)0.957
Mitogen-activated protein kinase 10Homo sapiens (human)1.4193
Mitogen-activated protein kinase 14Homo sapiens (human)0.15

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Do, EK; Kim, JH; Kim, KH; Kim, MY; Shin, SH; Song, HY1
Im, SY; Kim, HA; Kim, KJ; Lee, HK; Seo, KH1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pyrazolanthrone

ArticleYear
Platelet-activating factor receptor mediates oxidized low density lipoprotein-induced migration of bone marrow-derived mesenchymal stem cells.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2010, Volume: 26, Issue:4-5

    Topics: Anthracenes; Becaplermin; Bone Marrow Cells; Butadienes; Cell Movement; Humans; Imidazoles; Lipoproteins, LDL; Mesenchymal Stem Cells; Mitogen-Activated Protein Kinases; Nitriles; p38 Mitogen-Activated Protein Kinases; Platelet Activating Factor; Platelet Membrane Glycoproteins; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pyridines; Receptors, G-Protein-Coupled; RNA Interference; RNA, Small Interfering

2010
PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis.
    FEBS letters, 2012, Dec-14, Volume: 586, Issue:24

    Topics: Androstadienes; Animals; Anthracenes; Butadienes; Cell Line; Humans; Imidazoles; Lung Neoplasms; MAP Kinase Signaling System; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Platelet Activating Factor; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyridines; Wortmannin

2012